FrancophonIA/ELRC3.0 huggingface dataset:
English: A small amount of Byetta will always remain in the cartridge.
Slovenian: Majhna količina zdravila Byetta bo vedno ostala v vložku.
English: Clearance was significantly reduced by 84% in patients with end-stage renal disease receiving dialysis (see section 4.2).
Slovenian: Očistek se je značilno zmanjšal za 84 % pri bolnikih s končno stopnjo bolezni ledvic na dializi (glejte poglavje 4.2).
English: Consistent with the potentially immunogenic properties of protein and peptide pharmaceuticals, patients may develop anti-exenatide antibodies following treatment with immediate-release exenatide.
Slovenian: V skladu z morebitno imunogenimi lastnostmi beljakovinskih in peptidnih zdravilnih učinkovin, lahko bolniki po zdravljenju z eksenatidom v obliki s takojšnjim sproščanjem razvijejo protitelesa proti eksenatidu.
English: Do not use this medicine after the expiry date, which is stated on the label and the carton after ‘EXP'.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki in škatli poleg oznake 'EXP'.
English: STEP 6 Remove and Dispose of the Needle
Slovenian: KORAK 6 Odstranite in zavrzite iglo
English: Administration of exenatide has been shown to reduce food intake, due to decreased appetite and increased satiety.
Slovenian: Pokazali so, da dajanje eksenatida zmanjša vnos hrane zaradi zmanjšanega apetita in povečanja občutka sitosti.
English: Immediate-release exenatide has shown no adverse effects on lipid parameters.
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem ni pokazalo neželenih učinkov na maščobne parametre.
English: One injection of your pre-filled pen will give you your dose.
Slovenian: Z eno injekcijo vašega napolnjenega injekcijskega peresnika boste dobili vaš odmerek.
English: If you are having problems using your Byetta pen, contact your healthcare professional.
Slovenian: Če imate težave z uporabo vašega injekcijskega peresnika Byetta, se obrnite na zdravstvenega delavca.
English: For oral medicinal products that are particularly dependent on threshold concentrations for efficacy, such as antibiotics, patients should be advised to take those medicinal products at least 1 hour before immediate-release exenatide injection.
Slovenian: Za peroralna zdravila, katerih učinkovitost je zlasti odvisna od mejnih koncentracij, kot so antibiotiki, moramo bolnikom svetovati, da ta zdravila vzamejo najmanj 1 uro pred injiciranjem eksenatida v obliki s takojšnjim sproščanjem.
English: The mean apparent volume of distribution of exenatide following subcutaneous administration of a single dose of exenatide is 28 l.
Slovenian: Povprečna opažena prostornina porazdelitve eksenatida po subkutanem dajanju enkratnega odmerka eksenatida je 28 l.
English: • The liquid should be clear, colourless, and free of particles.
Slovenian: • Tekočina mora biti bistra, brezbarvna in brez delcev.
English: Help will be needed by a person trained to use the pen.
Slovenian: Te osebe potrebujejo pomoč osebe, usposobljene za uporabo injekcijskega peresnika.
English: • Never push the injection button on the pen unless a needle is attached.
Slovenian: • Nikoli ne pritisnite gumba za injiciranje injekcijskega peresnika, razen če je pritrjena igla.
English: The most common adverse events leading to withdrawal for immediate-release exenatide-treated patients were nausea (4% of patients) and vomiting (1%).
Slovenian: Najpogostejša neželena učinka, ki sta vodila v prekinitev pri bolnikih zdravljenih z eksenatidom v obliki s takojšnjim sproščanjem, sta bila navzea (4 % bolnikov) in bruhanje (1 %).
English: Becton, Dickinson and Company needles are suitable to use with the Byetta pen.
Slovenian: Igle proizvajalca Becton, Dickinson and Company so primerne za uporabo z injekcijskim peresnikom Byetta.
English: Both treatment arms were titrated to achieve target fasting plasma glucose levels (see section 5.1).
Slovenian: Obe veji zdravljenja sta bili titrirani za dosego ciljnih nivojev glukoze v krvi na tešče (glejte poglavje 5.1).
English: • If needed, wipe the outside of the pen with a clean, damp cloth.
Slovenian: • Če je potrebno, obrišite zunanjost injekcijskega peresnika s čisto, vlažno krpo.
English: Do I use a new needle for each injection?
Slovenian: Ali naj za vsako injiciranje uporabim novo iglo?
English: Exenatide exposure increased proportionally over the therapeutic dose range of 5 mcg to 10 mcg.
Slovenian: Izpostavljenost eksenatidu se je povečevala sorazmerno v razponu terapevtskih odmerkov od 5 μg do 10 μg.
English: The reduction in Cmax is of limited clinical relevance and no adjustment of dosing of oral contraceptives is required.
Slovenian: Znižanje Cmax ima omejeno klinično vrednost, zato prilagoditev odmerjanja peroralnih kontraceptivov ni potrebna.
English: Do not use this medicine if you notice particles in the solution, or if it is cloudy or coloured.
Slovenian: Tega zdravila ne uporabljajte, če v raztopini opazite delce ali je raztopina motna ali obarvana.
English: Check the symbol in the dose window.
Slovenian: Preverite oznako v okencu za odmerjanje.
English: Neonatal growth was reduced in mice exposed to high doses during late gestation and lactation.
Slovenian: Rast novorojenca je bila manjša pri miših izpostavljenih visokim odmerkom med pozno gestacijo in dojenjem.
English: The concurrent use of immediate-release exenatide with D-phenylalanine derivatives (meglitinides), alpha-glucosidase inhibitors, dipeptidyl peptidase-4 inhibitors or other GLP-1 receptor agonists has not been studied and cannot be recommended.
Slovenian: Sočasne uporabe eksenatida v obliki s takojšnjim sproščanjem z derivati D-fenilalanina (meglitinidi), zaviralci alfa-glukozidaze, zaviralci dipeptidil peptidaze-4 ali drugimi agonisti receptorja GLP-1 niso preučevali in je ne priporočamo.
English: C.OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Slovenian: C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM
English: High doses of exenatide during mid-gestation caused skeletal effects and reduced foetal growth in mice and reduced foetal growth in rabbits.
Slovenian: Visoki odmerki eksenatida med srednjo gestacijo so povzročili učinke na okostju in manjšo rast ploda pri miših ter manjšo rast ploda pri kuncih.
English: The liquid should be clear, colourless, and free of particles.
Slovenian: Tekočina mora biti bistra, brezbarvna in brez delcev.
English: Hypoglycaemia was reported in 11% and 7% of patients treated with exenatide and placebo respectively.
Slovenian: O hipoglikemiji so poročali pri 11 % in 7 % bolnikov, zdravljenih z eksenatidom oziroma placebom.
English: Immediate-release exenatide is not expected to have any clinically relevant effects on the pharmacokinetics of metformin or sulphonylureas.
Slovenian: Ne pričakujemo, da bi eksenatid v obliki s takojšnjim sproščanjem imel klinično pomembne učinke na farmakokinetiko metformina ali sulfonilsečnin.
English: There is little experience with this medicine in patients with kidney problems
Slovenian: Malo je izkušenj z uporabo tega zdravila pri bolnikih, ki imajo težave z ledvicami.
English: Excipients This medicinal product contains metacresol, which may cause allergic reactions.
Slovenian: Pomožne snovi To zdravilo vsebuje metakrezol, ki lahko povzroča alergijske reakcije.
English: Set up your new pen just before you use it for the first time.
Slovenian: Vaš novi injekcijski peresnik pripravite tik preden ga boste prvič uporabili.
English: A pharmacodynamic study demonstrated in patients with type 2 diabetes (n=13) a restoration of first phase insulin secretion and improved second phase insulin secretion in response to an intravenous bolus of glucose.
Slovenian: Farmakodinamična študija je pri bolnikih z diabetesom tipa 2 (n=13) pokazala obnovo prve faze izločanja insulina in izboljšanje druge faze izločanja insulina kot odgovor na intravenski bolus glukoze.
English: Date of first use Date to throw away pen
Slovenian: Datum prve uporabe Datum, ko boste zavrgli injekcijski peresnik
English: • To prevent this, for your next dose, firmly push and hold the injection button in and slowly count to 5 (see Section 3, Step 4: Inject the Dose).
Slovenian: • Da to preprečite, pri naslednjem odmerku čvrsto pritisnite in držite gumb za injiciranje ter počasi štejete do 5 (glejte Poglavje 3, Korak 4: Injicirajte odmerek).
English: Immediate-release exenatide can be administered at any time within the 60-minute period before the morning and evening meal (or two main meals of the day, approximately 6 hours or more apart).
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem lahko damo kadarkoli v roku 60-minut pred jutranjim in večernim obrokom (ali dvema glavnima dnevnima obrokoma, ki sta približno 6 ur ali več narazen).
English: Long-term controlled data in elderly are limited, but suggest no marked changes in exenatide exposure with increased age up to about 75 years old.
Slovenian: Podatki o dolgotrajni nadzorovani uporabi pri starejših so omejeni, vendar z večanjem starosti vse do približno 75 leta starosti ne kažejo izrazitih sprememb v izpostavitvi eksenatidu.
English: Exenatide is cleared primarily by the kidney, therefore hepatic dysfunction is not expected to affect blood concentrations of exenatide.
Slovenian: Eksenatid se izloča zlasti preko ledvic, zato ne pričakujemo, da bi okvara jeter vplivala na koncentracije eksenatida v krvi.
English: • Section 3 of this manual should be used for every injection.
Slovenian: • Uporabite Poglavje 3 teh navodil pri vsakem injiciranju.
English: • If you repeat the New Pen Setup before each routine dose, you will not have enough Byetta for 30 days.
Slovenian: • Če pred vsakim rednim odmerjanjem ponovite pripravo novega injekcijskega peresnika, ne boste imeli dovolj zdravila Byetta za 30 dni.
English: The reduction in HbA1c was sustained and the weight loss continued for at least 82 weeks in the subset of 10 mcg BID patients completing both the placebo-controlled studies and the uncontrolled study extensions (n=137).
Slovenian: Zmanjšanje HbA1c je bilo trajno in zmanjševanje telesne mase se je nadaljevalo najmanj 82 tednov pri skupini bolnikov z 10 μg dvakrat na dan, ki so dokončali podaljšanja tako s placebom nadzorovanih kot nenadzorovanih študij (n=137).
English: It is not known if exenatide passes into your milk.
Slovenian: Ni znano ali eksenatid prehaja v materino mleko.
English: For routine use, do not repeat the New Pen Setup.
Slovenian: Za vsakodnevno uporabo, ne ponavljajte Priprave novega injekcijskega peresnika.
English: STEP 4 Inject the Dose
Slovenian: KORAK 4 Injicirajte odmerek
English: Ethinyl estradiol and levonorgestrel
Slovenian: Etinilestradiol in levonorgestrel
English: Administration of the oral contraceptive 30 minutes after immediate-release exenatide did not affect AUC but resulted in a reduction of the Cmax of ethinyl estradiol by 45%, and Cmax of levonorgestrel by 27-41%, and a delay in tmax by 2-4 h due to delayed gastric emptying.
Slovenian: Dajanje peroralnega kontraceptiva 30 minut po dajanju eksenatida v obliki s takojšnjim sproščanjem ni vplivalo na AUC, vendar je povzročilo znižanje Cmax etinildiestrola za 45 % in Cmax levonorgestrela za 27-41 % na zakasnitev tmax za 2-4 ure zaradi upočasnjenega praznjenja želodca.
English: - If you have severe kidney disease or you are on dialysis, as the use of this medicine is not recommended.
Slovenian: - Če imate hudo bolezen ledvic ali ste na dializi, ker se uporabe tega zdravila v tem primeru ne priporoča.
English: When exenatide is used in combination with a sulphonylurea or a basal insulin, patients should be advised to take precautions to avoid hypoglycaemia while driving and using machines.
Slovenian: Kadar eksenatid uporabljamo v kombinaciji s sulfonilsečnino ali bazalnim insulinom, moramo bolnikom svetovati o previdnostnih ukrepih, da bi se med vožnjo in upravljanjem s stroji izognili hipoglikemiji.
English: It is an injectable medicine used to improve blood sugar control in adults with type 2 (non-insulin dependent) diabetes mellitus.
Slovenian: To je zdravilo za injiciranje, ki ga uporabljamo za izboljšanje nadzora sladkorja v krvi pri odraslih s sladkorno boleznijo tipa 2 (od insulina neodvisno).
English: Rare side effects (may affect up to 1 in 1,000 people): • intestinal obstruction (blockage in intestine)
Slovenian: Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): • zapora črevesa (blokada v črevesu)
English: If you lose weight too quickly (more than 1.5 kg per week) talk to your doctor about it since this may cause problems such as gallstones.
Slovenian: Če telesno maso izgubljate prehitro (več kot 1,5 kg na teden), se pogovorite s svojim zdravnikom, saj to lahko povzroči težave z žolčnimi kamni.
English: What you need to know before you use Byetta
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Byetta
English: − For tablets that you need to take with food, it may be best if they are taken at a meal at a time when this medicine is not being administered.
Slovenian: - tablete, ki jih morate vzeti s hrano, je morda najbolje, da jih vzamete med obrokom, v času ko ne uporabite zdravila Byetta.
English: • Check that the is in the dose window.
Slovenian: • Preverite, ali je v okencu za odmerjanje .
English: The 26-week study showed similar results with statistically significant reductions from baseline HbA1c compared to placebo (-0.8% versus -0.1%).
Slovenian: 26-tedenska študija je pokazala podobne rezultate, s statistično značilnim zmanjšanjem HbA1c od izhodiščne vrednosti v primerjavi s placebom (-0,8 % proti -0,1 %).
English: At the end of the study, immediate-release exenatide (n=137) demonstrated a statistically significant reduction in the HbA1c and weight compared to placebo (n=122).
Slovenian: Po koncu študije (n=137) je eksenatid v obliki s takojšnjim sproščanjem pokazalo statistično pomembno zmanjšanje HbA1c in telesne mase v primerjavi s placebom (n=122).
English: EXP Discard pen 30 days after first use.
Slovenian: EXP Injekcijski peresnik zavrzite 30 dni po prvi uporabi.
English: Byetta is a clear and colourless liquid (solution for injection) filled in a glass cartridge within a pen.
Slovenian: Zdravilo Byetta je bistra in brezbarvna tekočina (raztopina za injiciranje), napolnjena v steklen vložek v injekcijskem peresniku.
English: In patients with mild (creatinine clearance 50 to 80 ml/min) or moderate renal impairment (creatinine clearance 30 to 50 ml/min), exenatide clearance was mildly reduced compared to clearance in individuals with normal renal function (13% reduction in mild and 36% reduction in moderate renal impairment).
Slovenian: Pri bolnikih z blago (očistek kreatinina 50 do 80 ml/min) ali zmerno okvaro ledvic (očistek kreatinina 30 do 50 ml/min), se je očistek eksenatida blago zmanjšal v primerjavi z očistkom pri posameznikih z normalnim delovanjem ledvic (13 % zmanjšanje pri blago in 36 % zmanjšanje pri zmerni okvari ledvic).
English: Treatment differences (immediate-release exenatide minus comparator) were -4.1 kg in the 26-week study and -5.4 kg in the 52-week study.
Slovenian: Razlike med zdravljenji (eksenatid v obliki s takojšnjim sproščanjem minus primerjalna snov) so bile -4,1 kg v 26-tedenski študiji in -5,4 kg v 52-tedenski študiji.
English: The small amount of Byetta used in the New Pen Setup will not affect the 30-day supply of Byetta.
Slovenian: Majhna količina zdravila Byetta, ki se porabi pri pripravi novega injekcijskega peresnika, ne bo vplivala na zagotovitev količine zdravila Byetta za 30 dni.
English: Immediate-release exenatide should be used with caution in patients receiving oral medicinal products that require rapid gastrointestinal absorption and medicinal products with a narrow therapeutic ratio.
Slovenian: Eksenatida v obliki s takojšnjim sproščanjem moramo uporabljati previdno pri bolnikih, ki dobivajo zdravila za peroralno uporabo, ki zahtevajo hitro absorpcijo v prebavilih in zdravila z ozkim terapevtskim razmerjem.
English: Patients who develop antibodies to exenatide tend to have more injection site reactions (for example: redness of skin and itching), but otherwise similar rates and types of adverse events as those with no antiexenatide antibodies.
Slovenian: Pri bolnikih, ki so razvili protitelesa proti eksenatidu, se je pogosteje pojavila reakcija na mestu injiciranja (na primer rdečica na koži ali srbenje), sicer pa so imeli podobne stopnje in vrste neželenih učinkov kot tisti brez protiteles proti eksenatidu.
English: Using too much of this medicine can cause nausea, vomiting, dizziness, or symptoms of low blood sugar (see section 4).
Slovenian: Uporaba prevelikega odmerka zdravila Byetta lahko povzroči slabost, bruhanje, omotico ali simptome nizkega sladkorja v krvi (glejte poglavje 4).
English: For additional information, contact your healthcare professional.
Slovenian: Za dodatne informacije, se obrnite na zdravstvenega delavca.
English: Byetta is also indicated as adjunctive therapy to basal insulin with or without metformin and/or pioglitazone in adults who have not achieved adequate glycaemic control with these medicinal products.
Slovenian: Zdravilo Byetta je indicirano tudi kot dodatno zdravljenje ob bazalnem insulinu z ali brez metformina in/ali pioglitazona pri odraslih, ki niso dosegli zadostnega glikemičnega nadzora s temi zdravili.
English: During the study both treatment arms titrated insulin glargine using an algorithm reflecting current clinical practice to a target fasting plasma glucose of approximately 5.6 mmol/l.
Slovenian: Med študijo sta obe veji zdravljenja titrirali insulin glargin z uporabo algoritma, ki je odražal trenutno klinično prakso, za dosego koncentracije glukoze v krvi na tešče približno 5,6 mmol/l.
English: The dose of exenatide can then be increased to 10 mcg BID to further improve glycaemic control.
Slovenian: Odmerek eksenatida lahko nato povečujemo do 10 μg dvakrat na dan z namenom nadaljnjega izboljšanja glikemičnega nadzora.
English: Immediate-release exenatide must not be administered by intravenous or intramuscular injection.
Slovenian: Eksenatida v obliki s takojšnjim sproščanjem ne smemo uporabljati za intravensko ali intramuskularno injiciranje.
English: The dose of immediate-release exenatide does not need to be adjusted on a day-by-day basis depending on self-monitored glycaemia.
Slovenian: Odmerka eksenatida v obliki s takojšnjim sproščanjem dnevno ni potrebno prilagajati glede na bolnikov samonadzor glikemije.
English: Table 1: Adverse reactions of immediate-release exenatide identified from clinical trials and spontaneous reports
Slovenian: Preglednica 1: Neželeni učinki eksenatida v obliki s takojšnjim sproščanjem, ugotovljeni v kliničnih preskušanjih in na podlagi spontanih poročil
English: Immediate-release exenatide improves glycaemic control through the immediate and sustained effects of lowering both postprandial and fasting glucose concentrations in patients with type 2 diabetes.
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem izboljša glikemični nadzor s takojšnjimi in trajnimi učinki zniževanja tako postprandialne koncentracije glukoze kot koncentracije glukoze na tešče pri bolnikih z diabetesom tipa 2.
English: Pruritus, and/ or urticaria
Slovenian: Srbenje in/ali koprivnica
English: Premeal blood glucose concentrations were generally lower in patients taking insulin compared to immediate-release exenatide.
Slovenian: Koncentracije glukoze v krvi pred obrokom so bile na splošno nižje pri bolnikih, ki so jemali insulin v primerjavi z eksenatidom v obliki s takojšnjim sproščanjem.
English: Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1).
Slovenian: Eksenatid je agonist na receptorju za glukagonu podobnem peptidu (GLP-1), ki kaže nekaj antihiperglikemičnih učinkov glukagonu podobnega peptida-1 (GLP-1).
English: When 1000 mg paracetamol was given with 10 mcg immediate-release exenatide (0 h) and 1 h, 2 h and 4 h after immediate-release exenatide injection, paracetamol AUCs were decreased by 21%, 23%, 24% and 14% respectively; Cmax was decreased by 37%, 56%, 54% and 41%, respectively; tmax was increased from 0.6 h in the control period to 0.9 h, 4.2 h, 3.3 h, and 1.6 h, respectively.
Slovenian: Ob dajanju 1000 mg paracetamola z 10 μg eksenatida v obliki s takojšnjim sproščanjem (0 ur), 1 uro, 2 uri in 4 ure po injiciranju eksenatida v obliki s takojšnjim sproščanjem, so se AUC-ji paracetamola posamezno zmanjšali za 21 %, 23 %, 24 % in 14 %; Cmax se je posamezno zmanjšal za 37 %, 56 %, 54 %, in 41 %; tmax se je posamezno povečal od 0,6 ure v kontrolnem obdobju na 0,9 ure, 4,2 ure, 3,3 ure in 1,6 ure.
English: • Follow Section 2 only to set up a new pen before first use.
Slovenian: • Sledite Poglavju 2 samo za pripravo novega injekcijskega peresnika pred prvo uporabo.
English: In both treatment groups, subjects continued to titrate their insulin glargine doses using an algorithm reflecting current clinical practice.
Slovenian: Preiskovanci v obeh terapevtskih skupinah so še naprej titrirali odmerke insulina glargina na podlagi algoritma, ki odraža trenutno klinično prakso.
English: Immediate-release exenatide-treated patients in the open-label extension studies at 82 weeks experienced similar types of adverse events observed in the controlled trials.
Slovenian: Bolniki zdravljeni z eksenatidom v obliki s takojšnjim sproščanjem v odprtih 82 tednov trajajočih razširjenih študijah so imeli podobne neželene učinke kot so bili opaženi v nadzorovanih preskušanjih.
English: Keep holding the injection button in and slowly count to 5.
Slovenian: Še naprej držite gumb za injiciranje pritisnjen in počasi štejte do 5.
English: Warnings and precautions Talk to your doctor, pharmacist, or diabetes nurse before using Byetta about the following: - Using this medicinein combination with a sulphonylurea, as low blood sugar (hypoglycaemia) can occur.
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom uporabe zdravila Byetta se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro iz diabetološke ambulante o naslednjem: - O uporabi tega zdravila v kombinaciji s sulfonilsečnino, ker lahko pride do nizkega sladkorja v krvi (hipoglikemije).
English: • Injection is complete when the is in the centre of the dose window.
Slovenian: • Injiciranje je zaključeno, ko je v sredini okenca za odmerjanje .
English: Follow the New Pen Setup only once.
Slovenian: Sledite Pripravi novega injekcijskega peresnika samo enkrat.
English: Seven-point self-monitored blood glucose profiles (before and after meals and at 3 am) demonstrated significantly reduced glucose values compared to insulin in the postprandial periods after immediate-release exenatide injection.
Slovenian: Sedem-točkovni samo ocenjevani profili glukoze v krvi (pred in po obrokih in ob 3h zjutraj) so pokazali značilna zmanjšanja vrednosti glukoze v primerjavi z insulinom v postprandialnih obdobjih po injiciranju eksenatida v obliki s takojšnjim sproščanjem.
English: When immediate-release exenatide is added to existing metformin and/or pioglitazone therapy, the current dose of metformin and/or pioglitazone can be continued as no increased risk of hypoglycaemia is anticipated, compared to metformin or pioglitazone alone.
Slovenian: Kadar eksenatid v obliki s takojšnjim sproščanjem dodamo k že uvedenemu zdravljenju z metforminom in/ali pioglitazonom, lahko nadaljujemo s predpisanim odmerkom metformina in/ali pioglitazona, saj ne pričakujemo povečanega tveganja za hipoglikemijo, v primerjavi s samim metforminom ali pioglitazonom.
English: What Byetta is and what it is used for What you need to know before you use Byetta How to use Byetta
Slovenian: Kaj je zdravilo Byetta in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Byetta Kako uporabljati zdravilo Byetta Možni neželeni učinki
English: Immediate-release exenatide is recommended for use in patients with type 2 diabetes mellitus who are already receiving metformin, a sulphonylurea, pioglitazone and/or a basal insulin.
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem priporočamo za uporabo pri bolnikih z diabetesom mellitusom tipa 2, ki že dobivajo metformin, sulfonilsečnino, pioglitazon in/ali bazalni insulin.